Occam Recruits CSO for Public Gene Therapy Company, Adverum
In February 2024, Occam recruited Romuald “Romu” Corbau, PhD as Chief Scientific Officer for Adverum Biotechnologies (Nasdaq: ADVM).
Corbau has over 25 years of life science experience, ranging from startups to global pharmaceutical companies in the United States and Europe. He joins Adverum from GenEdit, where he served as Chief Scientific Officer. Prior to joining GenEdit, Corbau progressed from Vice President of Research to Chief Scientific Officer at Freeline. Before GenEdit, Corbau was the Translational Lead at Spark Therapeutics and held various research positions at Pfizer, CISTIM in Belgium, and Children’s Hospital of Philadelphia.
Recent Placements
Occam Global is a leading executive search and advisory partner for entrepreneurs, investors, and corporations targeting exceptional goals across the life sciences, deep tech, and venture capital sectors worldwide. Since 2012, Occam has collaborated with top founders, CEOs, and investors across the tech industry to provide high-performing leaders who fuel growth. From stealth startups to public markets, we recruit senior executives, advise on organizational strategies, and invest alongside visionary teams to build innovative companies. Occam’s success is rooted in our proven ability to attract outstanding business and scientific leaders, seamless access to rare talent, and a strong commitment to results guided by high ethics and enlightened aggression. Whether you’re launching, leading, or investing, we are here to support growth through the power of talent.